PARADIGM BIOPHARMACEUTICALS LIMITED.. (ASX:PAR) - MOZZ Research - First Half 2021, page-12 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum

Originally posted by Mozzarc: ↑

Mozz Research July 2020 - December 2020

TITLE................................................................................DATE PUBLISHED

1 to 100 Bagger - Part 1................................................... 30/12/2020
1 to 100 Bagger - Part 2................................................... 30/12/2020
1 to 100 Bagger - Part 3................................................... 30/12/2020
AGM - 2020: Mozz Notes Part 1...................................... 19/11/2020
AGM - 2020: Mozz Notes Part 2...................................... 21/11/2020
Alzheimer's and the iPPS connection Part 1................... 11/10/2020
Alzheimer's and the iPPS connection Part 2................... 11/10/2020
Andrew Walker's Story..................................................... 21/07/2020
ARDS & PAR................................................................... 23/09/2020
Aspirin - The new Aspirin iPPS........................................15/08/2020
Back Pain - Part 1............................................................25/07/2020
Back Pain - Part 2............................................................25/07/2020
BML and the patent..........................................................29/10/2020
Covid 19 and de risking PAR............................................30/09/2020
Deal Comparison - Momenta.............................................7/11/2020
Dividends and PAR...........................................................29/07/2020
Donkey Experiment and iPPS............................................8/08/2020
Dosing Study......................................................................8/09/2020
EAP - The Merits................................................................7/07/2020
Emerging Leaders Conference.........................................17/09/2020
ESG and PAR....................................................................8/12/2020
Heart Failure - MyoKardia takeover...................................6/10/2020
How much should I invest in PAR?...................................18/07/2020
How to Pick ME? (PAR)....................................................18/08/2020
IND and PAR - Part 1.........................................................5/09/2020
IND and PAR - Part 2.........................................................5/09/2020
INDIA.................................................................................4/08/2020
Interview with a FDA Process expert Part 1....................20/09/2020
Interview with a FDA Process expert Part 2....................20/09/2020
Kidneys and PAR.............................................................22/08/2020
MPS - An Update.............................................................15/07/2020
MPS - Tablet -v- SubQ Part 1...........................................26/09/2020
MPS - Tablet -v- SubQ Part 2...........................................26/09/2020
MPS - The Role Play........................................................12/09/2020
New Staff Appointments...................................................13/10/2020
Numbers are wrong!.........................................................11/07/2020
Obesity and the Hand OA connection..............................27/10/2020
PAR AND P/E Ratio...........................................................2/07/2020
Pep Talk and PAR -Part 1.................................................29/08/2020
Pep Talk and PAR -Part 2.................................................29/08/2020
PhD - NO and the DMOAD magic of iPPS - Part 1...........12/12/2020
PhD - NO and the DMOAD magic of iPPS - Part 2...........12/12/2020
Pricing of iPPS................................................................ .22/10/2020
Proof of PAR.....................................................................18/07/2020
Research (Mysterious) Tie-Up..........................................15/09/2020
Ross River Fever - Queensland connection.......................3/10/2020
SPORT and OA..................................................................4/07/2020
Stay the course.................................................................14/07/2020
TGA and the Traffic light timetable....................................30/10/2020
Yin and the Yang Part 2...................................................17/10/2020

Pre July 2020

47............................................................................................7/3/2020
A GOOD DEAL....................................................................28/10/2019
A MATTER OF SUPPLY.........................................................28/09/2019
A RARE DISEASE IN THE FAST LANE.................................30/12/2019
ANNUAL REPORT INSIGHTS............................................11/09/2019
AREAS OF COMPETENCY...................................................6/2/2020
ASTHMA 1...........................................................................20/6/2020
ASTHMA 2...........................................................................20/6/2020
BIG PHARMA DEAL.............................................................5/6/2020
BMEL AND THE % OF OA....................................................8/09/2020
CANCER...............................................................................9/11/2019
CASE STUDY.......................................................................31/5/2020
CHINA.................................................................................17/11/2019
CHOLESTEROL..................................................................28/3/2020
CHRON'S DISEASE............................................................13/07/2019
CLINICAL TRIALS.............................................................16/3/2019
COMPARING PAR TO PNV................................................12/10/2019
COMP THE BIOMARKER...................................................13/4/2019
COMPARING PAR TO COKE..............................................24/12/2019
COMPARING PAR AND A2M.............................................24/5/2020
COMPARING PAR AND CUV..............................................4/5/2019
COMPARING PAR AND SRX 1............................................6/4/2019
COMPARING PAR AND SRX 2...........................................19/5/2020
COMPETITION AND THEIR SIDE EFFECTS.......................23/3/2019
COPD...................................................................................22/6/2019
DID YOU KNOW - MPS.......................................................14/09/2019
DID YOU KNOW -OA...........................................................10/08/2019
DURABILITY........................................................................9/4/2020
EAP.....................................................................................4/03/2020
EAP TIMINGS....................................................................13/6/2020
ENDPOINTS........................................................................3/09/2020
ENDPOINTS AND THIRD PHASE.......................................2/4/2020
FAST TRACK.......................................................................25/5/2019
FOUR LANED HIGHWAY.....................................................4/4/2020
GLPG1972..........................................................................20/9/2020
GOING IT ALONE................................................................31/08/2020
GOOD DOCTOR 1...............................................................20/11/2019
GOOD DOCTOR 2...............................................................18/01/2020
GOOD DOCTOR 3...............................................................14/06/2020
GROWTH...........................................................................28/6/2019
HAY FEVER.......................................................................26/11/2019
HEART................................................................................28/4/2019
HUMAN MAD COW DISEASE...........................................22/2/2020
INFLAMMATION...............................................................30/9/2019
INFOGRAPHIC 1...............................................................12/05/2020
INFOGRAPHIC 2...............................................................12/05/2020
INFOGRAPHIC 3................................................................6/05/2020
JAPAN...............................................................................14/03/2020
JIM CRAMER......................................................................7/6/2020
MADE IN GERMANY 1.......................................................24/5/2020
MADE IN GERMANY 2.......................................................24/05/2020
MARKET PENETRATION 1...............................................15/02/2020
MARKET PENETRATION 2...............................................15/02/2020
MEDIA CHANNELS...........................................................25/04/2020
MENISCUS TEAR...............................................................11/01/2020
MOAT AND THE RECIPE FOR SUCCESS 1.......................3/5/2020
MOAT AND THE RECIPE FOR SUCCESS 2.........................3/05/2020
MPS.....................................................................................3/08/2019
MPS AND THE COST OF TREATMENT.............................23/04/2020
MRA.....................................................................................18/04/2020
NGF AND WHY COMPETITION DOESNT WORK...............8/02/2020
OA - ARE WE SERIOUS.......................................................1/2/2020
PAIN....................................................................................16/4/2019
PAIN AND THE PRECIPICE.................................................2/11/2019
PAIN RELIEF.......................................................................6/10/2019
PGIC....................................................................................27/6/2019
PRE IND..............................................................................25/01/2019
PSORIASIS..........................................................................20/07/2019
RECRUITING FOR A PHASE 3...........................................25/01/2020
SALE PROJECTION 1........................................................9/5/2020
SALE PROJECTION 2.......................................................28/6/2020
SHORT SQUEEZE............................................................25/02/2020
SPECIAL PROFILE - PAUL RENNIE...................................21/03/2020
SPECIAL PROFILE - SIMON WHITE..................................20/01/2020
STAR RATING SYSTEM...................................................19/10/2019
SYMPOSIUM....................................................................9/01/2020
TGA PROVISIONAL TIMETABLE.....................................26/10/2019
THE BILLION DOLLAR TIMELINE 1...............................16/09/2019
THE BILLION DOLLAR TIMELINE 2.................................7/02/2020
THE CLUE.......................................................................21/05/2020
THIRD PHASE TRIAL AND DESIGN.............................16/07/2019
TIMETABLE 1................................................................27/02/2020
TIMETABLE 2.................................................................23/06/2020
TIMETABLE UPDATE.....................................................17/06/2019
TIMINGS AND TIMETABLES.........................................30/03/2019
VIRUS.............................................................................27/01/2020
WHAT A PAIN................................................................29/02/2020
YEAR 1 REVENUE.........................................................14/02/2020
YIN AND YANG..............................................................2/10/2019

Expand

Great reference point for all Mozz's posts. I had forgotten a few and have already re-read them.
Hopefully we will all soon benefit from Mozz's dedication and endless hours of research.
Thanks Mozz.

(20min delay)
Last 23.0¢		Change 0.010(4.55%)		Mkt cap ! $80.45M

Open	High	Low	Value	Volume
22.8¢	23.3¢	22.5¢	$46.92K	203.9K

No.	Vol.	Price($)
1	337	0.230
4	84610	0.225
14	174871	0.220
6	73458	0.215
5	131050	0.210

Price($)	Vol.	No.
0.235	138166	5
0.250	15000	1
0.260	26050	3
0.270	13000	2
0.275	10000	1

MOZZ Research - First Half 2021, page-12

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

Emerald & Azure score Digger & Dealer awards

Bitcoin: Current State of Play & Where to Next | Swyftx

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

MOZZ Research - First Half 2021, page-12

Top Stories

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

Emerald & Azure score Digger & Dealer awards

Bitcoin: Current State of Play & Where to Next | Swyftx

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News